Does LEMBOREXANT Cause Hepatic function abnormal? 15 Reports in FDA Database
Wake Up Pain-Free — Sleep Like Never Before
Derila Ergo Pillow: ergonomic design, cooling tech. 75% OFF today.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Hepatic function abnormal have been filed in association with LEMBOREXANT (DAYVIGO). This represents 1.5% of all adverse event reports for LEMBOREXANT.
15
Reports of Hepatic function abnormal with LEMBOREXANT
1.5%
of all LEMBOREXANT reports
1
Deaths
9
Hospitalizations
How Dangerous Is Hepatic function abnormal From LEMBOREXANT?
Of the 15 reports, 1 (6.7%) resulted in death, 9 (60.0%) required hospitalization.
Is Hepatic function abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEMBOREXANT. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does LEMBOREXANT Cause?
Drug ineffective (225)
Suicide attempt (98)
Somnolence (90)
Suicidal ideation (86)
Sleep paralysis (80)
Condition aggravated (74)
Nightmare (71)
Altered state of consciousness (45)
Off label use (45)
Adverse drug reaction (44)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
Which LEMBOREXANT Alternatives Have Lower Hepatic function abnormal Risk?
LEMBOREXANT vs LENACAPAVIR
LEMBOREXANT vs LENALIDOMIDE
LEMBOREXANT vs LENIOLISIB
LEMBOREXANT vs LENOGRASTIM
LEMBOREXANT vs LENVATINIB